Identifying the serotonin transporter signal in Western blot studies of the neurotoxic potential of MDMA and related drugs

Synapse

Volumn 65, Issue 12, 2011, Pages 1368-1372

  Mclane, Michael W ^a   Mccann, Una ^a   Ricaurte, George ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Electrophoresis; Fenfluramine; MDMA; Neurotoxicity; SERT

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5,7 DIHYDROXYTRYPTAMINE; CHLORAMPHETAMINE; FENFLURAMINE; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; KNOCKOUT MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DOWN-REGULATION; GENE KNOCKOUT TECHNIQUES; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PREDICTIVE VALUE OF TESTS; RATS; SEROTONIN; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 80051619167     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20958     Document Type: Article

References (22)

1. Ahmed BA, Jeffus BC, Bukhari SI, Harney JT, Unal R, Lupashin VV, van der Sluijs P, Kilic F. 2008. Serotonin transamidates Rab4 and facilitates its binding to the C terminus of serotonin transporter. J Biol Chem 283: 9388-9398.
2. Baumann MH, Wang X Rothman RB. 2007. 3, 4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology (Berl) 189: 407-424.
3. Biezonski DK, Meyer JS. 2010. Effects of 3, 4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. J Neurochem 112: 951-962.
4. Bhide NS, Lipton JW, Cunningham JI, Yamamoto BK, Gudelsky GA. 2009. Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain. Brain Res 1286: 32-41.
5. Cunningham JI, Raudensky J, Tonkiss J, Yamamoto BK. 2009. MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning. Behav Neurosci 123: 1076-1084.
6. Horschitz S, Lau T, Schloss P. 2008. Glycine residues G338 and G342 are important determinants for serotonin transporter dimerisation and cell surface expression. Neurochem Int 52(4-5): 770-775.
7. Kilic FRudnick G. 2000. Oligomerization of serotonin transporter and its functional consequences. Proc Natl Acad Sci USA 97: 3106-3111.
8. Kish SJ, Furukawa Y, Chang LJ, Tong J, Ginovart N, Wilson A, Houle S, Meyer JH. 2005. Regional distribution of serotonin transporter protein in postmortem human brain: Is the cerebellum a SERT-free brain region? Nucl Med Biol 32: 123-128.
9. Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y. 2008. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain 131(Part 1): 120-131.
10. Kivell B, Day D, Bosch P, Schenk S, Miller J. 2010. MDMA causes a redistribution of serotonin transporter from the cell surface to the intracellular compartment by a mechanism independent of phospho-p38-mitogen activated protein kinase activation. Neuroscience 168: 82-95.
11. McLane MW, Hatzidimitriou G, Yuan J, McCann U, Ricaurte G. 2007. Heating induces aggregation and decreases detection of serotonin transporter protein on Western blots. Synapse 61: 875-876.
12. Ozaslan D, Wang S, Ahmed BA, Kocabas AM, McCastlain JC, Bene A, Kilic F. 2003. Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter. A specific role for sialic acid residues. J Biol Chem 278: 43991-4000.
13. Prasad HC, Zhu CB, McCauley JL, Samuvel DJ, Ramamoorthy S, Shelton RC, Hewlett WA, Sutcliffe JS, Blakely RD. 2005. Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proc Natl Acad Sci USA 102: 11545-11550.
14. Qian Y, Melikian HE, Rye DB, Levey AI, Blakely RD. 1995. Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. J Neurosci 15: 1261-1274.
15. Rasmussen TN, Plenge P, Bay T, Egebjerg J, Gether U. 2009. A single nucleotide polymorphism in the human serotonin transporter introduces a new site for N-linked glycosylation. Neuropharmacology 57: 287-294.
16. Rothman RB, Jayanthi S, Wang X, Dersch CM, Cadet JL, Prisinzano T, Rice KC, Baumann MH. 2003. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Synapse 50: 233-239.
17. Rothman RB, Jayanthi S, Cadet JL, Wang X, Dersch CM, Baumann MH. 2004. Substituted amphetamines that produce long-term serotonin depletion in rat brain amphetamines that produce long-term serotonin depletion in rat brain ("neurotoxicity") do not decrease serotonin transporter protein expression. Ann N Y Acad Sci 1025: 151-161.
18. Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S. 2005. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: Evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci 25: 29-41.
19. Wang X, Baumann MH, Xu H, Rothman RB. 2004. 3, 4-ethylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Synapse 53: 240-248.
20. Wang X, Baumann MH, Xu H, Morales M, Rothman RB. 2005. (+/-)-3, 4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane. J Pharmacol Exp Ther 314: 1002-1012.
21. Wang X, Baumann MH, Dersch CM, Rothman RB. 2007. Restoration of 3, 4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan. Neuroscience 148: 212-220.
22. Xie T, Tong L, McLane MW, Hatzidimitriou G, Yuan J, McCann U, Ricaurte G. 2006. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines. Neuropsychopharmacology 12: 2639-2651. Epub 2006 Jan 25. Erratum in Neuropsychopharmacology 2008 33:712-713.